MFN2 and pulmonary arterial hypertension: Mfn2 deficiency, which contributes to mitochondrial fragmentation in PAH and lung cancer, results in part from increased proteasomal degradation triggered by PINK1-induced phosphorylation of S442 of Mfn2 [145].